Successful treatment of eosinophilic cellulitis with a short course of Dupilumab
Open Access
- 15 January 2025
- journal article
- case report
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 100 (2) , 401-403
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Clinical Entity Mimicking Infectious Cellulitis: Eosinophilic Cellulitis (Wells’ Syndrome)Infectious Diseases and Clinical Microbiology, 2023
- Revolutionizing Dupilumab Treatment in Refractory Eosinophilic Cellulitis: A Case Report and Comprehensive Literature ReviewCureus, 2023
- Efficacy and safety of dupilumab up to 52 weeks in adults and adolescents with eosinophilic oesophagitis (LIBERTY EoE TREET study): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialThe Lancet Gastroenterology & Hepatology, 2023
- Atypical Wells Syndrome Successfully Treated with DupilumabSkin Health and Disease, 2023
- Wells syndrome successfully treated with dupilumabInternational Journal of Dermatology, 2022
- Dupilumab in eosinophilic cellulitis (Wells’ syndrome) – case report of a potential new treatment optionJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2021
- Eosinophilic cellulitis successfully treated with MethotrexateAustralasian Journal of Dermatology, 2020
- Eosinophilic Dermatoses: Recognition and ManagementAmerican Journal of Clinical Dermatology, 2020
- Eosinophilic Skin Diseases: A Comprehensive ReviewClinical Reviews in Allergy & Immunology, 2015
- Distinguishing cellulitis from its mimicsCleveland Clinic Journal of Medicine, 2012